Welcome to the new Independent website. We hope you enjoy it and we value your feedback. Please contact us here.

Health News

New test allows surgeons to detect spread of breast cancer tumours immediately

The RD-100i OSNA system will spare sufferers the agony of waiting up to three weeks for results

Thousands of breast cancer patients could be spared agonising waits to find out whether they need follow-up surgery thanks to a new test that can detect whether a cancer has spread during the initial operation to remove a tumour.

Currently patients have to wait for up to three weeks for tests from their initial surgery to confirm whether or not a cancer has spread, but the new test allows surgeons to detect spread in the operating theatre itself and intervene immediately - removing the need for a second operation.

The new test - the RD-100i OSNA system, produced by health technology firm Sysmex - has now been recommended by the National Institute of Health and Care Excellence.

Every year, around 11,000 people with newly diagnosed breast cancer need additional surgery to manage the spread of the disease to the lymph nodes. Second operations can be more dangerous than the first, so the new test could improve survival rates.

Early intervention to remove any cancerous lymph nodes at the same time as the initial tumour also allows subsequent treatments like chemotherapy to be carried out earlier.

Professor Carole Longson, director of NICE's health technology evaluation centre said: “For people with breast cancer and their families, waiting to hear if the disease has spread can cause significant distress and anxiety. If the test is positive, and a second operation is needed to remove more of the axillary lymph nodes, the second operation can be technically more difficult and result in a higher risk of complications because it will involve operating on the same area of the breast and armpit as the first operation.”

The cost of the hardware for the RD-100i OSNA system is around £70,000, NICE said.

Breast cancer is one of the most common cancers in women. There are 46,000 new cases in England and Wales each year, and 10,900 recorded deaths.